FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2279137978> ?p ?o ?g. }

• W2279137978 endingPage "477" @default.
• W2279137978 startingPage "471" @default.
• W2279137978 abstract "Iron deficiency disrupts dopaminergic signaling in rodents, resulting in cognitive deficits that may be reversed with psychostimulants. In humans, iron deficiency with or without anemia has similarly been found to cause neuropsychological and behavioral impairments. However, the clinical effects of low body iron stores in antipsychotic-treated children have not been examined.Medically healthy, 5- to 17-year-old boys treated with risperidone for at least 1 year were enrolled between February 2009 and November 2013 in a multiphase study, examining the skeletal effects of calcium and vitamin D supplementation in risperidone-induced hyperprolactinemia. Anthropometric measures were collected and medical and pharmacy records were reviewed to obtain treatment history. Psychiatric diagnoses were based on clinical interviews, structured interviews, rating scales, and a review of their medical records. Extrapyramidal symptoms were assessed, and a food frequency questionnaire was completed in a subsample. Laboratory tests, including ferritin concentration (a marker of body iron status), were obtained upon study entry.A total of 114 participants (mean age: 11.0 ± 2.6 years) were included, the vast majority (>90%) having attention-deficit/hyperactivity disorder and/or disruptive behavior disorder. They had taken risperidone for an average 3.1 ± 2.0 years. Their serum ferritin concentration was 37.3 ± 25.6 μg/L with 21% of the sample having a level <20 μg/L, despite appropriate daily dietary iron intake. Ferritin concentration was inversely associated with weight gain following risperidone treatment onset but was not significantly associated with prolactin. After adjusting for the weight-adjusted dose of psychostimulants and risperidone and the daily dose of selective serotonin reuptake inhibitors, ferritin was inversely associated with the severity of disruptive behavior and positively associated (albeit marginally) with prosocial behavior. No association was found between ferritin concentration and extrapyramidal symptoms.Body iron stores are inversely related to risperidone-induced weight gain, even after extended treatment and despite adequate iron intake. Low iron stores are associated with poorer treatment response. Future research should examine iron absorption during antipsychotic treatment and whether repleting iron stores would facilitate clinical response." @default.
• W2279137978 created "2016-06-24" @default.
• W2279137978 creator A5060269539 @default.
• W2279137978 creator A5069598980 @default.
• W2279137978 creator A5082380296 @default.
• W2279137978 creator A5089456610 @default.
• W2279137978 date "2016-06-01" @default.
• W2279137978 modified "2023-10-18" @default.
• W2279137978 title "Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth" @default.
• W2279137978 cites W1561199896 @default.
• W2279137978 cites W193716579 @default.
• W2279137978 cites W1970305055 @default.
• W2279137978 cites W1971331868 @default.
• W2279137978 cites W1986215944 @default.
• W2279137978 cites W1987562093 @default.
• W2279137978 cites W1993593650 @default.
• W2279137978 cites W1999689270 @default.
• W2279137978 cites W2007684928 @default.
• W2279137978 cites W2018659765 @default.
• W2279137978 cites W2020162931 @default.
• W2279137978 cites W2021031709 @default.
• W2279137978 cites W2028619198 @default.
• W2279137978 cites W2030956785 @default.
• W2279137978 cites W2033214187 @default.
• W2279137978 cites W2041177334 @default.
• W2279137978 cites W2047110339 @default.
• W2279137978 cites W2050958518 @default.
• W2279137978 cites W2053355831 @default.
• W2279137978 cites W2056162538 @default.
• W2279137978 cites W2062991497 @default.
• W2279137978 cites W2068095019 @default.
• W2279137978 cites W2070251324 @default.
• W2279137978 cites W2073271820 @default.
• W2279137978 cites W2080534262 @default.
• W2279137978 cites W2083792513 @default.
• W2279137978 cites W2094315023 @default.
• W2279137978 cites W2094369975 @default.
• W2279137978 cites W2101810617 @default.
• W2279137978 cites W2107383758 @default.
• W2279137978 cites W2107915720 @default.
• W2279137978 cites W2117351174 @default.
• W2279137978 cites W2123715670 @default.
• W2279137978 cites W2125738714 @default.
• W2279137978 cites W2130150209 @default.
• W2279137978 cites W2132087610 @default.
• W2279137978 cites W2133011785 @default.
• W2279137978 cites W2140974602 @default.
• W2279137978 cites W2147854221 @default.
• W2279137978 cites W2148288398 @default.
• W2279137978 cites W2151297547 @default.
• W2279137978 cites W2157215879 @default.
• W2279137978 cites W2159759971 @default.
• W2279137978 cites W2160227090 @default.
• W2279137978 cites W2162536793 @default.
• W2279137978 cites W2165379748 @default.
• W2279137978 cites W2290461407 @default.
• W2279137978 cites W2406565888 @default.
• W2279137978 cites W2408214815 @default.
• W2279137978 cites W582605298 @default.
• W2279137978 doi "https://doi.org/10.1089/cap.2015.0194" @default.
• W2279137978 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4931353" @default.
• W2279137978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26894929" @default.
• W2279137978 hasPublicationYear "2016" @default.
• W2279137978 type Work @default.
• W2279137978 sameAs 2279137978 @default.
• W2279137978 citedByCount "10" @default.
• W2279137978 countsByYear W22791379782020 @default.
• W2279137978 countsByYear W22791379782021 @default.
• W2279137978 countsByYear W22791379782022 @default.
• W2279137978 countsByYear W22791379782023 @default.
• W2279137978 crossrefType "journal-article" @default.
• W2279137978 hasAuthorship W2279137978A5060269539 @default.
• W2279137978 hasAuthorship W2279137978A5069598980 @default.
• W2279137978 hasAuthorship W2279137978A5082380296 @default.
• W2279137978 hasAuthorship W2279137978A5089456610 @default.
• W2279137978 hasBestOaLocation W22791379782 @default.
• W2279137978 hasConcept C118552586 @default.
• W2279137978 hasConcept C126322002 @default.
• W2279137978 hasConcept C147583825 @default.
• W2279137978 hasConcept C15744967 @default.
• W2279137978 hasConcept C187212893 @default.
• W2279137978 hasConcept C2776412080 @default.
• W2279137978 hasConcept C2778319317 @default.
• W2279137978 hasConcept C2780057945 @default.
• W2279137978 hasConcept C2780320433 @default.
• W2279137978 hasConcept C2780494398 @default.
• W2279137978 hasConcept C2780616385 @default.
• W2279137978 hasConcept C71924100 @default.
• W2279137978 hasConceptScore W2279137978C118552586 @default.
• W2279137978 hasConceptScore W2279137978C126322002 @default.
• W2279137978 hasConceptScore W2279137978C147583825 @default.
• W2279137978 hasConceptScore W2279137978C15744967 @default.
• W2279137978 hasConceptScore W2279137978C187212893 @default.
• W2279137978 hasConceptScore W2279137978C2776412080 @default.
• W2279137978 hasConceptScore W2279137978C2778319317 @default.
• W2279137978 hasConceptScore W2279137978C2780057945 @default.
• W2279137978 hasConceptScore W2279137978C2780320433 @default.
• W2279137978 hasConceptScore W2279137978C2780494398 @default.

• next